Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tegaserod maleate (SDZ-HTF-919) 是选择性5-HT4受体的部分激动剂和5-HT2B 受体的拮抗剂,用于治疗肠易激综合征和便秘。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 197 | 现货 | ||
10 mg | ¥ 328 | 现货 | ||
25 mg | ¥ 655 | 现货 | ||
50 mg | ¥ 978 | 现货 | ||
100 mg | ¥ 1,470 | 现货 | ||
200 mg | ¥ 2,270 | 待询 | ||
500 mg | ¥ 4,150 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 349 | 现货 |
产品描述 | Tegaserod maleate (SDZ-HTF-919) is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation. Its use was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating and constipation associated with irritable bowel syndrome. On March 30, 2007, the U.S. Food and Drug Administration requested that Novartis withdraw Zelnorm from shelves. The FDA alleges a relationship between prescriptions of the drug and increased risks of heart attack or stroke. |
别名 | HTF-919, 马来酸替加色罗, SDZ-HTF-919 |
分子量 | 417.46 |
分子式 | C20H27N5O5 |
CAS No. | 189188-57-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 35 mg/mL
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Tegaserod maleate 189188-57-6 GPCR/G Protein Neuroscience 5-HT Receptor HTF-919 5-hydroxytryptamine Receptor IBS irritable Tegaserod Maleate 马来酸替加色罗 Gastrointestinal HTF 919 Tegaserod syndrome bowel SDZ-HTF 919 SDZ-HTF919 Inhibitor inhibit SDZ-HTF-919 Serotonin Receptor HTF919 inhibitor